Metformin lowers risk of long COVID
Treatment with the diabetes drug metformin immediately after testing positive for the SARS-CoV-2 virus lowers the risk of developing long COVID by 41%. Researchers reported this finding on […]
Treatment with the diabetes drug metformin immediately after testing positive for the SARS-CoV-2 virus lowers the risk of developing long COVID by 41%. Researchers reported this finding on […]
Sleep apnea may significantly increase the risk for long COVID in adults, according to a study led by the National Institutes of Health’s RECOVER Initiative and supported by NYU Langone […]
Children, adolescents and adults have recorded significant new illnesses across 13 distinct diagnosis and symptom complexes after infection with COVID-19, according to a new study published in PLOS Medicine by […]
Matchday performance of professional footballers dropped after recovering from COVID-19 with three quarters fighting fatigue for six weeks, a University of Essex study has found. The study – […]
People who suffer long-term consequences of Covid-19 can experience a wide range of symptoms. As the precise nature and duration of Long Covid is still being untangled by […]
Researchers report that two years after diagnosis half of patients hospitalized with COVID-19 have at least one ongoing symptom. The findings appeared in on May 11, 2022 in […]
Even vaccinated people with mild breakthrough COVID-19 infections can experience debilitating, lingering symptoms that affect the heart, brain, lungs and other parts of the body, according to new […]
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.